Macrolides for the treatment of COVID-19: a living, systematic review
Randomized trials evaluating macrolide use in the treatment of coronaviruses showed no beneficial effects compared to standard of care. The evidence for all outcomes is inconclusive. Larger trials are needed to determine the effects of Macrolides on pulmonary and other outcomes.

Related Post